Status:
RECRUITING
Hyperbaric Oxygen Therapy for Optic Neuropathies
Lead Sponsor:
Stanford University
Conditions:
Optic Neuropathy
Glaucoma
Eligibility:
All Genders
18+ years
Phase:
NA
Brief Summary
The purpose of the study is to evaluate the neuroprotective efficacy of hyperbaric oxygen for the treatment in patients with optic neuropathy.
Eligibility Criteria
Inclusion
- Patients must meet all of the following criteria to join the study (all eligibility criteria must be met at the screening and baseline visits unless otherwise noted):
- Participant must be at least 18.
- Participant must has the ability to comply with the requirements of the study and complete the schedule of events (SOE).
- Participant's with clinical evidence of optic neuropathy.
- Participant must understand and sign the informed consent. If the participant's vision is impaired to the point where he/she cannot read the informed consent document, the document will be read to the participant in its entirety.
Exclusion
- Participant is unable to comply with study procedures or follow-up visits.
- Participant has evidence of corneal opacification or lack of optical clarity.
- Participant is currently participating in or has within the last 3 months participated in any other clinical trial of a drug by ocular (if in the study eye) or systemic administration.
- Participant is pregnant or lactating.
- Participant has, in the opinion of the investigator, any physical or mental condition that would increase the risk of participation in the study or may interfere with the study procedures, evaluations and outcome assessments.
- Children and comatose patients.
- Participant abusing drugs or alcohol.
- Prior treatment with hyperbaric oxygen within the last 6 months.
- Participant with claustrophobia or that cannot decompress properly.
Key Trial Info
Start Date :
November 1 2022
Trial Type :
INTERVENTIONAL
Allocation :
ESTIMATED
End Date :
December 1 2027
Estimated Enrollment :
60 Patients enrolled
Trial Details
Trial ID
NCT06128720
Start Date
November 1 2022
End Date
December 1 2027
Last Update
May 25 2025
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Byers Eye Institute
Palo Alto, California, United States, 94303